Literature DB >> 17055550

The neutralizing antibody response against West Nile virus in naturally infected horses.

Melissa D Sánchez1, Theodore C Pierson, Marciela M Degrace, Lisa M Mattei, Sheri L Hanna, Fabio Del Piero, Robert W Doms.   

Abstract

A major neutralizing epitope (here referred to as the T332 epitope) located on the lateral surface of domain III (DIII) of the West Nile virus (WNV) envelope protein has been identified based on the analysis of murine monoclonal antibodies. However, little is known about the humoral immune response against WNV in a natural host or whether DIII in general or the T332 epitope in particular are important targets of neutralizing antibodies in vivo. To characterize the types of antibodies produced during infection with WNV, we studied a group of naturally infected horses. Using immune adsorption assays coupled with the use of virus particles bearing mutations in the T332 epitope, we found that in some animals neutralizing activity against DIII and the T332 epitope was below the limit of detection. In contrast, some animals generated a significant fraction of neutralizing activity to DIII and the T332 epitope. Thus, while antibodies to the T332 epitope did not represent a significant fraction of the total antibody response in the infected animals studied, in some horses, they comprised a significant fraction of neutralizing activity, making this an important but far from dominant neutralizing epitope. Rather, the neutralizing response to WNV generated in infected horses is both variable and polyclonal in nature, with epitopes within and outside of DIII playing important roles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055550     DOI: 10.1016/j.virol.2006.08.047

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

1.  Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.

Authors:  Juergen Zlatkovic; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

2.  Recombinant dengue type 2 viruses with altered e protein domain III epitopes are efficiently neutralized by human immune sera.

Authors:  Wahala M P B Wahala; Claire Huang; Siritorn Butrapet; Laura J White; Aravinda M de Silva
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  Use of a surrogate chimeric virus to detect West Nile virus-neutralizing antibodies in avian and equine sera.

Authors:  Nicholas Komar; Stanley Langevin; Thomas P Monath
Journal:  Clin Vaccine Immunol       Date:  2008-11-12

4.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

Authors:  Camilo Ansarah-Sobrinho; Steevenson Nelson; Christiane A Jost; Stephen S Whitehead; Theodore C Pierson
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

Review 5.  Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Expert Rev Mol Med       Date:  2008-05-12       Impact factor: 5.600

6.  An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.

Authors:  Akane Urakami; Mya Myat Ngwe Tun; Meng Ling Moi; Atsuko Sakurai; Momoko Ishikawa; Sachiko Kuno; Ryuji Ueno; Kouichi Morita; Wataru Akahata
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 7.  Antibody-mediated neutralization of flaviviruses: a reductionist view.

Authors:  Kimberly A Dowd; Theodore C Pierson
Journal:  Virology       Date:  2011-01-20       Impact factor: 3.616

8.  Induction of epitope-specific neutralizing antibodies against West Nile virus.

Authors:  Theodore Oliphant; Grant E Nybakken; S Kyle Austin; Qing Xu; Jonathan Bramson; Mark Loeb; Mark Throsby; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.

Authors:  Matthew R Vogt; Bastiaan Moesker; Jaap Goudsmit; Mandy Jongeneelen; S Kyle Austin; Theodore Oliphant; Steevenson Nelson; Theodore C Pierson; Jan Wilschut; Mark Throsby; Michael S Diamond
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

10.  Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody.

Authors:  W M P B Wahala; Annette A Kraus; Laura B Haymore; Mary Ann Accavitti-Loper; Aravinda M de Silva
Journal:  Virology       Date:  2009-07-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.